Dermapharm AG-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Dermapharm AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013148
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Dermapharm AG (Dermapharm) is a pharmaceutical company that offers dermatological and allergy medicines. The company provides products for allergies, disinfection and wound treatment, skin and hair care, corticoids, minerals, osteoporosis, fungal infections, vaginal thrush, other preparations, specific skincare, vein problems and vitamins, among others. It provides products in the form of retards, nail polish, creams, gels, hair and normal solutions, tablets, chewable tablets, OSH creams, shampoos, liquids, liquid pump sprays, powder, ointment and suspensions, among others. The company distributes its products through a network of distributors in domestic and overseas markets. Dermapharm is headquartered in Grunwald, Germany.

Dermapharm AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Dermapharm AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Dermapharm AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Dermapharm AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Dermapharm AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Dermapharm AG, Medical Devices Deals, 2011 to YTD 2017 9
Dermapharm AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Dermapharm AG, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Dermapharm May Sell Itself 11
Acquisition 12
Dermapharm Rumored To Acquire Galenika 12
Dermapharm Acquires 95% Stake In Farmal, Generic Pharma Company 13
Dermapharm AG – Key Competitors 14
Dermapharm AG – Key Employees 15
Dermapharm AG – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Dermapharm AG, Pharmaceuticals & Healthcare, Key Facts 2
Dermapharm AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Dermapharm AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Dermapharm AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Dermapharm AG, Deals By Therapy Area, 2011 to YTD 2017 8
Dermapharm AG, Medical Devices Deals, 2011 to YTD 2017 9
Dermapharm AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Dermapharm May Sell Itself 11
Dermapharm Rumored To Acquire Galenika 12
Dermapharm Acquires 95% Stake In Farmal, Generic Pharma Company 13
Dermapharm AG, Key Competitors 14
Dermapharm AG, Key Employees 15
Dermapharm AG, Subsidiaries 16

★海外企業調査レポート[Dermapharm AG-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Flowonix Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Flowonix Medical Inc (Flowonix), formerly Medasys Inc is a medical device company that designs and manufactures implantable drug pump to deliver therapeutic drugs into the spine to relieve chronic disorders. The company's products include prometra pump, catheter, and accessories and programm …
  • Dai Nippon Printing Co Ltd (7912):企業の財務・戦略的SWOT分析
    Dai Nippon Printing Co Ltd (7912) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • LUX Island Resorts Ltd:企業の戦略・SWOT・財務情報
    LUX Island Resorts Ltd - Strategy, SWOT and Corporate Finance Report Summary LUX Island Resorts Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Coeur Mining Inc:企業の戦略・SWOT・財務分析
    Coeur Mining Inc - Strategy, SWOT and Corporate Finance Report Summary Coeur Mining Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Polydex Pharmaceuticals Ltd (POLXF):企業の財務・戦略的SWOT分析
    Summary Polydex Pharmaceuticals Ltd (PPL) is a manufacturer and marketer of pharmaceutical intermediates for human and veterinary pharmaceutical markets. The company manufactures and sells bulk quantities of dextran and derivative products. Its dextran and its derivatives can be used as adjuvants, e …
  • Hess Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Hess Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Hess Corp (Hess) is a global independent energy company which carries out the exploration and production of crude oil and natural gas. It primarily operates in US, Denmark, the Joint Development Area of Ma …
  • Fast Retailing Co., Ltd.:戦略・SWOT・企業財務分析
    Fast Retailing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Fast Retailing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Evgen Pharma Plc (EVG)-製薬・医療分野:企業M&A・提携分析
    Summary Evgen Pharma Plc (Evgen Pharma), formerly Evgen Pharma Ltd is a drug discovery company that develops medicines to treat cancer and neurological diseases. The company uses sulforadex technology that synthesizes and concurrently stabilizes the naturally occurring compound such as sulforaphane. …
  • Ctrip.com International, Ltd.:企業の戦略・SWOT・財務情報
    Ctrip.com International, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ctrip.com International, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Vaccinex Inc (VCNX):製薬・医療:M&Aディール及び事業提携情報
    Summary Vaccinex Inc (Vaccinex) is a clinical-stage biotechnology company that discovers and develops targeted biotherapeutics to treat neurodegenerative diseases, cancer and autoimmune disorders. The company’s lead platform technologies include antibody platform and ActivMAb, SEMA4D, and antibody d …
  • Philippine Long Distance Telephone Company:企業の戦略・SWOT・財務情報
    Philippine Long Distance Telephone Company - Strategy, SWOT and Corporate Finance Report Summary Philippine Long Distance Telephone Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Siemens Healthineers AG (SHL):企業の財務・戦略的SWOT分析
    Siemens Healthineers AG (SHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • True Diagnostics Inc:企業の製品パイプライン分析2018
    Summary True Diagnostics Inc (True Diagnostics) is a research, development and manufacturing company that offers in-vitro immunodiagnostic test systems and reagents. The company provides diagnostics such as self testing, point of care testing and companion diagnostics. It offers trueDX platform tech …
  • Penn National Gaming Inc:企業の戦略・SWOT・財務分析
    Penn National Gaming Inc - Strategy, SWOT and Corporate Finance Report Summary Penn National Gaming Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Elavon, Inc.:企業の戦略・SWOT・財務情報
    Elavon, Inc. - Strategy, SWOT and Corporate Finance Report Summary Elavon, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • 3D Signatures Inc (DXD):医療機器:M&Aディール及び事業提携情報
    Summary 3D Signatures Inc (3D Signatures) is a developer of diagnostic and prognostic products for cancers and neurological disorders. The company's pipeline products include 3D Telo-PC a tool that is used to treat prostate cancer. It also provides 3D Telo-RS a diagnostic and prognostic tool used fo …
  • EPAM Systems Inc (EPAM):企業の財務・戦略的SWOT分析
    EPAM Systems Inc (EPAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Metso Corporation:企業の戦略・SWOT・財務分析
    Metso Corporation - Strategy, SWOT and Corporate Finance Report Summary Metso Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Old Dominion Freight Line, Inc. (ODFL):企業の財務・戦略的SWOT分析
    Old Dominion Freight Line, Inc. (ODFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Impinj Inc (PI):企業の財務・戦略的SWOT分析
    Impinj Inc (PI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆